Vitamin C can kill Candida albicans in laboratory settings, sometimes dramatically so. One study found that a concentrated ascorbate solution reduced live Candida cells by a factor of 100,000 in just 90 minutes under the right conditions. But the distance between a lab dish and a human body is vast, and the handful of animal and cell studies that exist paint a far more complicated picture than “take vitamin C to fight yeast.” Some evidence even suggests vitamin C could interfere with standard antifungal drugs.
What Lab Studies Actually Show
The most striking finding comes from a study that exposed Candida albicans to sodium ascorbate (a form of vitamin C) at a concentration of 90 millimolar. When the solution was shaken to keep it well-oxygenated, viability of the yeast dropped by five orders of magnitude within an hour and a half. That is an enormous kill rate. But the same experiment without shaking produced no killing at all, and neither did running it at refrigerator temperature instead of body temperature. The yeast had to be actively metabolizing and surrounded by oxygen for the vitamin C to work.1PubMed Central. Sodium ascorbate kills Candida albicans in vitro via iron-catalyzed Fenton reaction: importance of oxygenation and metabolism
A separate in vitro study tested ascorbic acid against fluconazole-resistant Candida albicans and found it produced a larger zone of inhibition than other vitamins tested. At twice the minimum inhibitory concentration, cell viability dropped to about 29%, and staining techniques confirmed the yeast cells were dying from membrane damage rather than simply being slowed down.2PubMed. In Vitro and In Silico Analysis of Ascorbic Acid Towards Lanosterol 14-α-Demethylase Enzyme of Fluconazole-Resistant Candida albicans
These results sound impressive, and they are, within their context. The concentrations used in these experiments are far higher than anything your bloodstream would reach from oral supplementation. Taking a vitamin C tablet raises blood levels to maybe 70–80 micromoles per liter at best. The effective killing concentration in the first study was 90 millimolar, roughly a thousand times higher. This gap is the central reason researchers have not rushed to clinical trials.
How Vitamin C Damages Yeast Cells
The killing mechanism hinges on something called the Fenton reaction. Vitamin C, despite its reputation as an antioxidant in human cells, can act as a pro-oxidant in the presence of free iron. When ascorbate donates electrons to iron inside a Candida cell, it generates hydroxyl radicals, which are among the most destructive molecules in chemistry. These radicals tear through cell membranes, damage DNA, and overwhelm the yeast’s ability to repair itself.1PubMed Central. Sodium ascorbate kills Candida albicans in vitro via iron-catalyzed Fenton reaction: importance of oxygenation and metabolism
The requirement for active metabolism and oxygen makes sense in this framework. The yeast has to be metabolically active and taking up iron for the reaction to occur internally. When researchers added an iron-chelating compound to the mix, it blocked the killing entirely, confirming that iron was essential to the process. The ascorbate also depleted intracellular NADH, an energy-carrying molecule the yeast needs to survive.
This pro-oxidant behavior is context-dependent. In your own cells, vitamin C mostly acts as a protective antioxidant, neutralizing harmful reactive oxygen species. In microbial cells with different iron handling and antioxidant defenses, the chemistry tilts the other way. The same molecule can protect your cells and destroy a pathogen’s, at least in principle.
Blocking Candida’s Shape-Shifting
One of Candida albicans’ most dangerous traits is its ability to switch between a round yeast form and an elongated filamentous (hyphal) form. The filamentous form is more invasive, better at penetrating tissue, and more resistant to the immune system. Researchers have found that ascorbic acid interferes with this transition by disrupting a key regulatory pathway involving a protein called Hsp90. Specifically, vitamin C antagonizes the morphogenetic change triggered when Hsp90 function is impaired, working through a transcriptional regulator called Upc2.3PubMed Central. Ascorbic acid inhibition of Candida albicans Hsp90-mediated morphogenesis occurs via the transcriptional regulator Upc2
This is potentially significant because the yeast-to-hypha switch is a major virulence factor. Drugs that block this transition do not necessarily kill Candida outright, but they can keep it in a less aggressive form that the immune system handles more easily. Whether the concentrations of vitamin C achievable in human tissue are enough to interfere with this process in a real infection remains an open question, but it adds another dimension to how ascorbate interacts with this organism.
Vitamin C as an Enhancer for Other Compounds
Some of the more promising research involves vitamin C not as a standalone antifungal but as something that boosts the activity of other compounds. A 2024 study tested vitamin C in combination with theasaponins, natural compounds found in tea seeds. Adding vitamin C significantly lowered the concentration of theasaponins needed to inhibit Candida growth and increased the overall killing efficiency. The combination also did a better job suppressing virulence factors like adhesion, biofilm formation, and phospholipase activity than either compound alone.4PubMed Central. Ascorbic Acid Enhances the Inhibitory Effect of Theasaponins against Candida albicans
The mechanism mirrors what was described above. Yeast cells exposed to the combination showed higher levels of reactive oxygen species and worse mitochondrial damage than those exposed to either substance individually. In other words, vitamin C amplified the oxidative assault. Similar synergy was observed with honokiol, a compound derived from magnolia bark. Adding vitamin C to honokiol nearly doubled the proportion of Candida cells showing oxidative stress and worsened mitochondrial lipid damage, loss of mitochondrial DNA, and collapse of the mitochondrial membrane potential.5Journal of Microbiology and Biotechnology. Opposite effects of vitamin C and vitamin E on the antifungal activity of honokiol
These findings are interesting for drug development. If vitamin C can lower the effective dose of a natural antifungal compound, that could reduce side effects and resistance. But neither theasaponins nor honokiol are currently mainstream antifungal treatments in humans, so the clinical application is still theoretical.
The Fluconazole Problem
Here is where the story takes an uncomfortable turn for anyone considering vitamin C supplementation during a Candida infection. Fluconazole is one of the most commonly prescribed antifungal drugs. An animal study found that when mice with systemic Candida infections were given vitamin C alongside fluconazole, the antifungal effect of fluconazole was significantly reduced. Both oral doses (50 and 500 mg/kg) and injected doses (at the higher 500 mg/kg level) of ascorbic acid interfered with the drug’s ability to clear the infection.6PubMed. Ascorbic acid decreases the antifungal effect of fluconazole in the treatment of candidiasis
A clinical case report echoed this concern. Researchers documented a case of oral mucositis caused by Candida glabrata biofilms where the combination of fluconazole and ascorbic acid failed to clear the infection. The authors concluded that, unlike in bacterial infections where vitamin C sometimes helps antibiotics work better, ascorbic acid should not be used alongside fluconazole for Candida treatment.7PubMed Central. Oral mucositis caused by Candida glabrata biofilms: failure of the concomitant use of fluconazole and ascorbic acid
Why would vitamin C help kill Candida on its own but interfere with fluconazole? The likely explanation lies in their conflicting mechanisms. Fluconazole works by disrupting the fungal cell membrane, a process that benefits from a relatively stable oxidative environment. Vitamin C’s pro-oxidant activity at high concentrations creates a chaotic reactive oxygen species environment that, paradoxically, may trigger the yeast’s stress-response pathways and make it more resistant to membrane-targeting drugs. The antioxidant properties of vitamin C at lower concentrations could also protect the fungal cell from some of the secondary damage fluconazole causes.
This is not a small caveat. Fluconazole is the first-line treatment for most Candida infections in humans. If you are taking it for thrush, a vaginal yeast infection, or a systemic fungal infection, high-dose vitamin C supplementation could plausibly undermine your treatment. The evidence is limited to one animal study and one case report, but the potential for harm is real enough that researchers have explicitly warned against the combination.
What About the Immune System?
Beyond any direct antifungal effect, vitamin C supports the immune cells that fight Candida naturally. A 2025 study in mice with corneal fungal infections found that vitamin C promoted neutrophil infiltration to the site of infection in a dose-dependent manner, working through mast cells to recruit these first-responder immune cells. Once the neutrophils arrived, vitamin C enhanced their ability to kill fungi. It also dampened the excessive inflammatory signaling from macrophages and increased the orderly death of old neutrophils, helping the body clean up the battlefield without excessive tissue damage.8PubMed Central. Vitamin C enhances corneal fungal infection treatment in mice via chemotaxis and anti-inflammation
This dual role, recruiting more immune cells while also calming the inflammatory response, is arguably more relevant to real-world Candida infections than the direct killing effect. Vitamin C deficiency weakens immune function across the board, and people who are severely deficient are more susceptible to all kinds of infections, including fungal ones. Maintaining adequate vitamin C intake supports the immune system’s ability to keep Candida in check, which is how your body manages this organism day to day. Most people carry some Candida without illness; it only becomes a problem when the immune system or the local microbial balance fails.
Oral Health and Anti-Inflammatory Effects
Oral candidiasis (thrush) is one of the most common Candida infections, and the mouth is one area where topical vitamin C exposure might be more practical than systemic supplementation. Researchers exposed oral keratinocytes (the cells lining your mouth) to vitamin C at concentrations ranging from 0.1 to 2.5 millimolar and then challenged them with Candida albicans. The vitamin C was not toxic to the human cells, and at higher concentrations it actually increased their metabolic activity. When the cells were infected, vitamin C downregulated key inflammatory genes, specifically IL-8 and IL-1β, suggesting it could reduce the inflammatory damage that makes oral thrush so uncomfortable.9Future Microbiology. Ascorbic acid as a modulator of inflammatory response against Candida albicans
The researchers concluded that vitamin C could serve as an adjuvant to standard antifungal treatment for oral Candida infections, not because it kills the yeast directly at these concentrations, but because it reduces the inflammatory collateral damage. Thrush is painful largely because of the immune response to the fungus, not just the fungus itself. If vitamin C can dial down the inflammation without suppressing the antimicrobial response, that is a meaningful contribution. However, one interesting wrinkle: the study also found that vitamin C delayed cell migration at 48 and 72 hours, which could theoretically slow wound healing in the oral mucosa. The clinical significance of that delay is unclear.
Safety Concerns at High Doses
Given that the antifungal concentrations of vitamin C used in lab studies are extremely high, it is worth addressing what happens when people take large doses. The most well-documented risk is kidney damage. Your body converts some ingested vitamin C into oxalate, which is excreted through the kidneys. At normal dietary levels, this is not a problem. But doses of 1,000 mg per day or more can increase urinary oxalate excretion enough to raise the risk of calcium oxalate kidney stones.10PubMed Central. Total, Dietary, and Supplemental Vitamin C Intake and Risk of Incident Kidney Stones
In more extreme cases, high-dose vitamin C, particularly when given intravenously, has caused acute kidney injury through oxalate crystal deposits in the kidney tubules. Case reports during the COVID-19 pandemic documented patients developing oxalate nephropathy after high-dose intravenous vitamin C. Researchers noted that there is no universally established toxic dose, but that consequent hyperoxaluria can substantially aggravate kidney injury of any kind and delay recovery.11Kidney International Reports. Acute Tubular Injury and Oxalate Nephropathy Caused by Excessive Vitamin C Administration in 2 Patients With COVID-19 Chronic overconsumption has also been documented as a cause of renal oxalosis in people without pre-existing kidney disease.12PubMed Central. A case report of renal oxalosis and secondary hyperoxaluria due to chronic high vitamin C consumption
Anyone with existing kidney problems should be especially cautious. And anyone tempted by the lab results to megadose vitamin C as a Candida treatment should understand that the concentrations that kill yeast in a dish are not achievable through oral supplementation, so increasing your dose into potentially harmful territory gains you nothing against the infection while adding real kidney risk.
Why the Gap Between Lab and Clinic Is So Wide
The pattern across this research is consistent: vitamin C does interesting things to Candida in controlled settings, but translating that to human medicine faces several barriers that are not easily overcome. First, the effective concentrations in direct-killing studies are far beyond what oral or even typical intravenous supplementation achieves in blood or tissue. Second, the conditions required for optimal killing, vigorous oxygenation, active fungal metabolism, and the presence of free iron, are not reliably present at infection sites in the human body. Many Candida infections occur in environments that are relatively low in oxygen, like the gut or vaginal canal.
Third, and perhaps most critically, vitamin C’s interaction with existing antifungal drugs appears to be antagonistic rather than synergistic when it comes to the drugs people are actually prescribed. The compounds it does enhance, theasaponins and honokiol, are not standard treatments. If you have a Candida infection serious enough to warrant medical attention, you are going to be prescribed fluconazole or a similar azole antifungal, and the available evidence says vitamin C may make those drugs work less well.
The immune-support angle is the most defensible reason to care about vitamin C in the context of Candida. Making sure you are not deficient helps your immune system function as it should, and a well-functioning immune system is your primary defense against Candida overgrowth. But that is a general health argument, not a targeted antifungal strategy. The recommended dietary allowance of vitamin C, around 75 to 90 mg per day for most adults, is enough to support immune function without risking the side effects of megadosing.
Species Differences and Drug-Resistant Strains
Most of the research discussed here focuses on Candida albicans, which is the most common species causing human infections. But the landscape of Candida infections is shifting. Candida glabrata, Candida auris, and other non-albicans species are increasingly common, especially in healthcare settings, and they tend to be more resistant to standard antifungal drugs. The case report of failed fluconazole-plus-ascorbic-acid treatment specifically involved Candida glabrata biofilms, which are notoriously difficult to treat.7PubMed Central. Oral mucositis caused by Candida glabrata biofilms: failure of the concomitant use of fluconazole and ascorbic acid
Whether vitamin C has any direct activity against these other species has barely been studied. The Fenton reaction mechanism should theoretically work in any organism that takes up iron and produces reactive oxygen species, but the threshold concentrations, the susceptibility of different membrane compositions, and the robustness of each species’ antioxidant defenses all vary. The in vitro work on fluconazole-resistant Candida albicans is a start, but extending the results to other species is speculative at this point.2PubMed. In Vitro and In Silico Analysis of Ascorbic Acid Towards Lanosterol 14-α-Demethylase Enzyme of Fluconazole-Resistant Candida albicans
Candida auris in particular has become a public health concern due to its resistance to multiple drug classes and its ability to persist on hospital surfaces. No published data that I am aware of tests vitamin C specifically against Candida auris, which is a significant gap given how urgently new treatment options for that species are needed. Researchers interested in vitamin C’s antifungal potential would do well to test it against the organisms that current drugs struggle with most, rather than continuing to demonstrate activity against the species we can already treat reasonably well.